Patents/Assignees

Bicycletx Limited

20 patents in portfolio

US12606594utility2026
Heterotandem Bicyclic Peptide Complexes
0 cites
US12570695utility2026
Bicyclic Peptide Ligands Specific for Epha2
0 cites
US12540161utility2026
Linkers
0 cites
US12492224utility2025
Bicyclic Peptide Ligands Specific for PD-L1
0 cites
US12459974utility2025
Bicyclic Peptide Ligands Specific for Nectin-4
0 cites
US12435107utility2025
Heterotandem Bicyclic Peptide Complex
0 cites
US12378288utility2025
Multimeric Bicyclic Peptide Ligands
0 cites
US12350343utility2025
Bicyclic Peptide Ligands Specific for MT1-MMP
0 cites
US12150998utility2024
Bicyclic Peptide Ligands Specific for P-selectin
0 cites
US12049520utility2024
Bicyclic Peptide Ligands Specific for CD137
0 cites
US11970553utility2024
Heterotandem Bicyclic Peptide Complex
0 cites
US11970555utility2024
Bicyclic Peptide Ligands Specific for Transferrin Receptor 1 (tfr1)
0 cites
US11912792utility2024
Bicyclic Peptide Ligands Specific for Nectin-4
0 cites
US11904020utility2024
Bicyclic Peptide Ligands Specific for TREM2
0 cites
US11866518utility2024
Bicyclic Peptide Ligands Specific for TSLP
0 cites
US11833211utility2023
Methods of Suppression and Treatment of Disease Comprising Administering Bicycle Peptide Ligands Specific for Epha2
0 cites
US11730819utility2023
Peptide Derivatives Having Novel Linkage Structures
0 cites
US11696956utility2023
Bicyclic Peptide Ligands Specific for Epha2
0 cites
US11613560utility2023
Bicyclic Peptide Ligands Specific for OX40
0 cites
US11542304utility2023
Multimeric Bicyclic Peptide Ligands
0 cites